PubMed Health⌕ Search

PubMed · 2696895

Cellular aspects of brain development.

Abstract

The formation of the central nervous system begins early in development with the induction of the neural ectoderm on the dorsal surface of the embryo. Subsequently, the neural ectoderm plate changes its shape to form a neural groove and eventually, a neural tube. The wall of the neural tube is composed of germinal cells, collectively called the neuroepithelium, that produces neurons and glia throughout the central nervous system (CNS). Three points will be made about cellular production in the CNS: (1) The neuroepithelium forms expansions (brain vesicles), folds, and lobules characteristic of particular CNS regions. The hypothesis that neuroepithelial "anatomy" is a blueprint for proper anatomical development of the CNS will be discussed. (2) Using tritiated thymidine autoradiography in the developing rat, we have found that the neuroepithelium generates neuronal populations according to specific timetables during CNS organogenesis. Some populations are produced early in a 1-2 day period, others are produced later during a 5-7 day period, while still others are produced after birth for periods of a few weeks. (3) By exposing perinatal rat pups to low level X-irradiation, we find that killing neuronal precursors and young postmitotic neurons results in permanent reductions in the number of cells that constitute the targeted neuronal populations. Even though some development continues after the X-ray exposures, there is no compensatory increase in cell proliferation to replace the lost cells. The implications of this finding will be discussed in light of the permanence of neurotoxic insults during human CNS development.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S A Bayer. 1989. Cellular aspects of brain development.. https://pubmed.ncbi.nlm.nih.gov/2696895/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗